HDAC2 and metabolic dysfunction-associated steatotic liver disease: Studies have indicated a correlation between HDAC2 and ROS (van de Ven et al., 2017), with elevated HDAC2 expression potentially serving as a crucial link in the onset of OSA-induced NAFLD.